Arcadia Biosciences Inc (RKDA):企業の財務・戦略的SWOT分析

◆英語タイトル:Arcadia Biosciences Inc (RKDA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDCT35882FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Clean Technology
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥82,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥124,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Arcadia Biosciences Inc (Arcadia) is an agricultural and clean technology company that develops and commercializes agricultural products. Its major products include goodwheat branded ingredients, nutritional oils, animal nutrition and agricultural products. The company’s products exhibit traits include drought tolerance, herbicide tolerance, water use efficiency, nitrogen use efficiency, and salinity tolerance, among others. Arcadia offers its products to growers to improve productivity by reducing the need for key inputs such as fertilizer and water and by increasing tolerance to environmental stresses such as drought, heat and salinity. Arcadia is headquartered in Davis, California, the US.

Arcadia Biosciences Inc Key Recent Developments

Mar 30,2021: Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2020 Financial Results and Business Highlights
Mar 23,2021: Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2020 Financial Results and Business Highlights Conference Call
Feb 02,2021: L2 : Legal and Regulatory Events : GoodHemp Seed Varieties Earn AOSCA Certification
Jan 25,2021: Arcadia Biosciences (RKDA) Announces $25.1 Million Private Placement
May 07,2020: Arcadia Biosciences Significantly Expands Intellectual Property Portfolio with Four U.S. Patents

This comprehensive SWOT profile of Arcadia Biosciences Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Arcadia Biosciences Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Arcadia Biosciences Inc – Key Information
Arcadia Biosciences Inc – Overview
Arcadia Biosciences Inc – Key Employees
Arcadia Biosciences Inc – Key Employee Biographies
Arcadia Biosciences Inc – Key Operational Heads
Arcadia Biosciences Inc – Major Products and Services
Arcadia Biosciences Inc – History
Arcadia Biosciences Inc – Company Statement
Arcadia Biosciences Inc – Locations And Subsidiaries

Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Arcadia Biosciences Inc – Business Description
Arcadia Biosciences Inc – Corporate Strategy
Arcadia Biosciences Inc – SWOT Analysis
SWOT Analysis – Overview
Arcadia Biosciences Inc – Strengths
Arcadia Biosciences Inc – Weaknesses
Arcadia Biosciences Inc – Opportunities
Arcadia Biosciences Inc – Threats
Arcadia Biosciences Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Arcadia Biosciences Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Arcadia Biosciences Inc, Key Information
Arcadia Biosciences Inc, Key Ratios
Arcadia Biosciences Inc, Share Data
Arcadia Biosciences Inc, Major Products and Services
Arcadia Biosciences Inc, History
Arcadia Biosciences Inc, Key Employees
Arcadia Biosciences Inc, Key Employee Biographies
Arcadia Biosciences Inc, Key Operational Heads
Arcadia Biosciences Inc, Other Locations
Arcadia Biosciences Inc, Subsidiaries

Arcadia Biosciences Inc, Key Competitors
Arcadia Biosciences Inc, SWOT Analysis
Arcadia Biosciences Inc, Ratios based on current share price
Arcadia Biosciences Inc, Annual Ratios
Arcadia Biosciences Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Arcadia Biosciences Inc (RKDA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CAS Medical Systems Inc (CASM):医療機器:M&Aディール及び事業提携情報
    Summary CAS Medical Systems Inc (CASMED) is a medical device company that designs, manufactures and markets technologies and monitors. The company offers technologies and monitors that deliver patient data. Its products comprise FORE-SIGHT absolute tissue oximeter, blood pressure measurement technol …
  • Midatech Pharma US Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Midatech Pharma US Inc (Midatech Pharma), formerly DARA BioSciences, Inc., is a pharmaceutical company which focuses on the development and commercialization of cancer treatment and supportive care products. It is a subsidiary of Midatech Pharma Plc. The company’s product portfolio includes …
  • Guangzhou Wondfo Biotech Co Ltd (300482):医療機器:M&Aディール及び事業提携情報
    Summary Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that develops, manufactures and supplies rapid diagnostic reagents and related equipment. Its products include rapid quantitative test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo also of …
  • The Hongkong and Shanghai Hotels Ltd:企業の戦略・SWOT・財務情報
    The Hongkong and Shanghai Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary The Hongkong and Shanghai Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • My Health Direct Inc:医療機器:M&Aディール及び事業提携情報
    Summary My Health Direct Inc (MHD) is a healthcare technology company that offers web-based solutions for the management of healthcare appointments. The company helps clients in achieving incremental revenue growth and real-time cost containment savings. It offers products such as consumer direct an …
  • Sompo Japan Nipponkoa Holdings, Inc.:戦略・SWOT・企業財務分析
    Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Imdex Limited (IMD)-石油・ガス分野:企業M&A・提携分析
    Summary Imdex Limited (Imdex) is a provider of integrated technological solutions to the mineral industry. The company offers drilling fluids, drilling equipment, advanced downhole instrumentation, data management solution and analytical software for geological modeling through its AMC and REFLEX br …
  • Vermont Electric Cooperative Inc:企業の戦略的SWOT分析
    Vermont Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Apple Inc:企業のM&A・事業提携・投資動向
    Apple Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Apple Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Rehrig Pacific Company:企業の戦略的SWOT分析
    Rehrig Pacific Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • ITM Power Plc (ITM):電力:M&Aディール及び事業提携情報
    Summary ITM Power Plc (ITM Power) is a renewable energy company. It designs and manufactures hydrogen energy systems for clean fuel production and energy storage. The company develops equipment to convert renewable energy into a clean fuel that can be stored for use in transport, industrial, and res …
  • TransMontaigne Product Services LLC-石油・ガス分野:企業M&A・提携分析
    Summary TransMontaigne Product Services LLC (TransMontaigne), a subsidiary of NGL Energy Partners LP, is an energy company, which carries out distribution and marketing of a wide range of petroleum products. The company markets several products including unbranded gasoline, diesel fuel, heating oil, …
  • SK Innovation Co., Ltd.:企業の戦略・SWOT・財務情報
    SK Innovation Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Innovation Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • JenaValve Technology Inc:医療機器:M&Aディール及び事業提携情報
    Summary JenaValve Technology Inc (JenaValve Technology), a subsidiary of JenaValve Technology GmbH, is a medical device company that develops and manufactures transcatheter aortic valve replacement (TAVR) systems for transapical and transfemoral implantation. The company’s TAVR system is an investig …
  • University of Texas Health Science Center at San Antonio-医療機器分野:企業M&A・提携分析
    Summary University of Texas Health Science Center at San Antonio (UTHSCSA), a subsidiary of University of Texas System is an educational university that offers undergraduate, graduate, and research programs to physicians, biomedical scientists, aging and longevity, cancer, cardiovascular, diabetes, …
  • First Solar Inc (FSLR):企業の財務・戦略的SWOT分析
    First Solar Inc (FSLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Toyo Kanetsu K.K.:企業の戦略・SWOT・財務情報
    Toyo Kanetsu K.K. - Strategy, SWOT and Corporate Finance Report Summary Toyo Kanetsu K.K. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • SynCore Biotechnology Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary SynCore Biotechnology Co Ltd (SynCore), a subsidiary of Sinphar Pharmaceutical Co Ltd is a biopharmaceutial company that utilizes and in-licenses technologies to develop new drugs. The company’s pipeline products include SB01, SB02, SB03, SB04 and SB05. Its SB01 drug is a new chemical entity …
  • ISA Pharmaceuticals BV:製薬・医療:M&Aディール及び事業提携情報
    Summary ISA Pharmaceuticals BV (ISA Pharmaceuticals) is a developer of synthetic therapeutic vaccines for the treatment of cancer and persistent viral infections. The company’s pipeline products include ISA101, an immunotherapeutic vaccine for cervical cancer; MyISA, a personalized immunotherapy bas …
  • Therapix Biosciences Ltd (TRPX):製薬・医療:M&Aディール及び事業提携情報
    Summary Therapix Biosciences Ltd (Therapix), formerly Nasvax Ltd is a clinical stage biopharmaceutical company that focuses on the development of cannabinoid based pharmaceuticals for the treatment of central nervous system disorders. Therapix’s major product candidates include THX-110, for the trea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆